Mostrar el registro sencillo del ítem
dc.contributor.author | Estevez, Y. | |
dc.contributor.author | Quiliano, M. | |
dc.contributor.author | Burguete, A. | |
dc.contributor.author | Cabanillas Amado, Billy Joel | |
dc.contributor.author | Zimic-Peralta, Mirko Juan | |
dc.contributor.author | Málaga, E. | |
dc.contributor.author | Verastegui Pimentel, Manuela Renee | |
dc.contributor.author | Pérez-Silanes, S. | |
dc.contributor.author | Aldana, I. | |
dc.contributor.author | Monge, A. | |
dc.contributor.author | Castillo Pareja, Denis Helan | |
dc.contributor.author | Deharo, E. | |
dc.date.accessioned | 2022-01-18T19:26:46Z | |
dc.date.available | 2022-01-18T19:26:46Z | |
dc.date.issued | 2011 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/10853 | |
dc.description.abstract | Pyrazole and propenone quinoxaline derivatives were tested against intracellular forms of Leishmania peruviana and Trypanosoma cruzi. Both series were tested for toxicity against proliferative and non-proliferative cells. The pyrazole quinoxaline series was quite inactive against T. cruzi; however, the compound 2,6-dimethyl-3-f-quinoxaline 1,4-dioxide was found to inhibit 50% of Leishmania growth at 8.9 μM, with no impact against proliferative kidney cells and with low toxicity against THP-1 cells and murine macrophages. The compounds belonging to the propenone quinoxaline series were moderately active against T. cruzi. Among these compounds, two were particularly interesting, (2E)-1-(7-fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone and (2E)-3-(3,4,5-trimethoxy-phenyl)-1-(3,6,7-trimethyl-quinoxalin-2-yl)-propenone. The former possessed selective activity against proliferative cells (cancer and parasites) and was inactive against murine peritoneal macrophages; the latter was active against Leishmania and inactive against the other tested cells. Furthermore, in silico studies showed that both series respected Lipinski’s rules and that they confirmed a linear correlation between trypanocidal activities and LogP. Docking studies revealed that compounds of the second series could interact with the poly (ADP-ribose) polymerase protein of Trypanosoma cruzi. | en_US |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartofseries | Experimental Parasitology | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Female | en_US |
dc.subject | article | en_US |
dc.subject | controlled study | en_US |
dc.subject | animal cell | en_US |
dc.subject | Animals | en_US |
dc.subject | Mice | en_US |
dc.subject | mouse | en_US |
dc.subject | non|priority journal | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | Trypanocidal Agents | en_US |
dc.subject | human cell | en_US |
dc.subject | Trypanosoma cruzi | en_US |
dc.subject | Leishmania | en_US |
dc.subject | protozoal protein | en_US |
dc.subject | Leishmania peruviana | en_US |
dc.subject | correlation analysis | en_US |
dc.subject | cell proliferation | en_US |
dc.subject | amphotericin B | en_US |
dc.subject | Mice, Inbred BALB C | en_US |
dc.subject | Molecular Structure | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | growth inhibition | en_US |
dc.subject | Murinae | en_US |
dc.subject | antiprotozoal activity | en_US |
dc.subject | antitrypanosomal agent | en_US |
dc.subject | drug cytotoxicity | en_US |
dc.subject | Quinoxalines | en_US |
dc.subject | molecular docking | en_US |
dc.subject | Cercopithecus aethiops | en_US |
dc.subject | drug selectivity | en_US |
dc.subject | Vero Cells | en_US |
dc.subject | kidney cell | en_US |
dc.subject | computer model | en_US |
dc.subject | drug protein binding | en_US |
dc.subject | Macrophages, Peritoneal | en_US |
dc.subject | 1 (7 fluoro 3 methyl quinoxalin 2 yl) 3 (3,4,5 trimethoxyphenyl)propenone | en_US |
dc.subject | 2,6 dimethyl 3 f quinoxaline 1,4 dioxide | en_US |
dc.subject | 3 (3,4,5 trimethoxyphenyl) 1 (3,6,7 trimethyl quinoxalin 2 yl)propenone | en_US |
dc.subject | mathematical computing | en_US |
dc.subject | nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase | en_US |
dc.subject | peritoneum macrophage | en_US |
dc.subject | quinoxaline 1,4 oxide derivative | en_US |
dc.subject | Quinoxaline 1,4-di-N-oxide derivatives | en_US |
dc.subject | trimethoxyphenyl propenone | en_US |
dc.subject | trimethoxyphenyl pyrazole quinoxaline | en_US |
dc.title | Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1016/j.exppara.2011.01.009 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.07 | |
dc.relation.issn | 1090-2449 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |